Intelomed develops noninvasive medical devices and technology for monitoring cardiovascular stability, centered on its CVInsight® product. The company plans to introduce CVInsight® to the Hemodialysis industry and the Long-term Care and Nursing Home industry over the next several months. Intelomed secured $4M in Series A-1 funding to support its next stage. Management intends to use the proceeds to launch sales efforts and pursue additional clinical validations for newly implemented product features. The company was founded in 2005 by Frank Amoruso, who serves as President and CEO, and is based in Pittsburgh, Pennsylvania.

Total raised

$4M

Funding rounds

1

Latest round

Series A

Latest activity

Sep 2013